Brand vs. Generic: Addressing Non-Adherence, Secular Trends, and Non-Overlap

Lamar Hunt, Irene B. Murimi, Jodi B. Segal +3

While generic drugs offer a cost-effective alternative to brand name drugs, regulators need a method to assess therapeutic equivalence in a post market setting. We develop such a m…